论文信息 - The SGLT2 inhibitor Empagliflozin attenuates interleukin-17A-induced human aortic smooth muscle cell proliferation and migration by targeting TRAF3IP2/ROS/NLRP3/Caspase-1-dependent IL-1β and IL-18 secretion. - 字舞流文

The SGLT2 inhibitor Empagliflozin attenuates interleukin-17A-induced human aortic smooth muscle cell proliferation and migration by targeting TRAF3IP2/ROS/NLRP3/Caspase-1-dependent IL-1β and IL-18 secretion.

B. Chandrasekar | S. Mummidi | Y. Higashi | S. Bender | Tadashi Yoshida | A. Aroor | S. Sukhanov | Jacob J. Russell | V. DeMarco